A normal A1C is below 5.7%. This number represents the percentage of your red blood cells that have glucose attached to them, and it reflects your average blood sugar over the past two to three months. An A1C between 5.7% and 6.4% falls into the prediabetes range, and 6.5% or higher means diabetes.
How the A1C Test Works
Glucose in your bloodstream naturally sticks to hemoglobin, the protein inside red blood cells that carries oxygen. The more glucose circulating in your blood, the more hemoglobin gets coated. Since red blood cells live about three months before your body replaces them, measuring how much glucose is stuck to them gives a reliable picture of your blood sugar over that entire window. That’s why the test captures trends rather than a single moment, unlike a finger-stick glucose reading.
The Three A1C Categories
The American Diabetes Association defines three ranges:
- Normal: below 5.7%
- Prediabetes: 5.7% to 6.4%
- Diabetes: 6.5% or higher
These percentages translate to real blood sugar numbers. An A1C of 6% corresponds to an estimated average glucose of about 126 mg/dL. At 7%, that average rises to roughly 154 mg/dL. By 9%, you’re looking at an average around 212 mg/dL. The conversion formula is straightforward: multiply your A1C by 28.7, then subtract 46.7 to get estimated average glucose in mg/dL.
A result in the prediabetes range doesn’t mean diabetes is inevitable. It means your blood sugar is higher than optimal, and lifestyle changes at this stage can often bring it back down. A result at 6.5% or above, confirmed with a repeat test, leads to a diabetes diagnosis.
Targets Change With Age and Health
The “normal” cutoff of 5.7% applies to people without diabetes. Once someone has diabetes, the goal shifts to managing A1C at a safe target rather than pushing it back to a non-diabetic range. For most adults and children with diabetes, that target is below 7%. But the right number depends heavily on age and overall health.
Healthy older adults generally aim for an A1C below 7.5%. For older adults with significant health conditions, the target relaxes to 8% or lower, because aggressively lowering blood sugar in this group raises the risk of dangerous drops (hypoglycemia) without offering as much long-term benefit. For those in poor health or with cognitive decline, targets may go as high as 8.5%, which corresponds to an average glucose of about 200 mg/dL. At that point, the priority is avoiding both severe high and low blood sugar events and preserving quality of life.
A1C During Pregnancy
Pregnancy changes the picture in two ways. First, your body turns over red blood cells faster, which naturally lowers A1C readings slightly in all pregnant people, whether or not they have diabetes. Second, the stakes of high blood sugar during pregnancy are significant: elevated glucose raises the risk of birth defects, preeclampsia, preterm delivery, and larger-than-expected babies.
For people with diabetes who are planning a pregnancy, the recommended A1C is below 6.5% before conception. During pregnancy itself, the ideal target drops to below 6% if that can be maintained without causing dangerous low blood sugar episodes. If hypoglycemia becomes a problem, the goal can be relaxed to below 7%. Because of the faster red blood cell turnover, A1C during pregnancy is often checked monthly rather than every few months.
A1C also has a limitation in pregnancy: it averages out blood sugar highs and lows, so it can miss the post-meal spikes that most directly affect fetal growth. For that reason, daily glucose monitoring is the primary tool, with A1C serving as a secondary check.
When Results Can Be Misleading
The A1C test assumes your red blood cells have a normal lifespan and normal hemoglobin. Several conditions break those assumptions.
Hemoglobin variants, inherited differences in the structure of hemoglobin, can push A1C results falsely high or low depending on the lab method used. The most common variants are hemoglobin S (the sickle cell variant), hemoglobin E, hemoglobin C, and hemoglobin D. If you carry one of these traits, your doctor may need to use a specific testing method or rely on alternative blood sugar measures.
Anything that shortens red blood cell lifespan will artificially lower your A1C because the cells don’t have as long to accumulate glucose. This includes certain types of anemia, sickle cell disease, significant kidney disease, and liver failure. Conversely, conditions that extend red blood cell life can make A1C appear higher than your actual average glucose.
If you have any of these conditions and your A1C doesn’t match what your daily glucose readings suggest, the discrepancy likely reflects a testing limitation rather than a mystery.
How Often to Get Tested
If you don’t have diabetes and your results are normal, most guidelines don’t call for frequent retesting unless you have risk factors like obesity, a family history of diabetes, or a history of gestational diabetes. Your doctor can advise on timing based on your personal risk profile.
If you have diabetes and your blood sugar is well controlled on a stable treatment plan, testing every six months is generally sufficient. When blood sugar targets aren’t being met, or when your treatment is changing, every three months makes more sense so you and your doctor can see whether adjustments are working. People going through rapid health changes or dealing with severe blood sugar swings may need testing even more frequently.
What Your Number Means in Practice
A single A1C reading is a snapshot of a three-month trend, not a verdict. A result of 5.8% doesn’t mean you definitely have prediabetes if your previous results were 5.4%, since normal biological variation and temporary factors like illness or medication changes can shift the number. That’s why diagnoses typically require confirmation with a second test.
What makes the A1C useful is its ability to cut through day-to-day noise. Your blood sugar swings after every meal, during exercise, during sleep, and during stress. A fasting glucose test captures just one of those moments. The A1C captures the full picture, which is why it’s become the standard screening tool and the primary way people with diabetes track their long-term control.